RenalToolBox is an Innovative Training Network funded by the EU’s Marie Skłodowska-Curie actions. The project will run from 01 November 2018 to 31 October 2022. The overarching goal of our project is to develop novel tools and technologies to assess the safety and efficacy of cell-based regenerative medicine therapies with a focus on kidney disease.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 813839.
